Immediate Impact

2 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
3 intermediate papers

Works of S. Fenselau being referenced

Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects
1999

Author Peers

Author Last Decade Papers Cites
S. Fenselau 206 144 55 113 7 364
Thea Lousen 142 109 47 103 9 328
Gale H. Starich 176 164 68 155 19 388
Kimberly Cukier 141 200 47 59 7 355
Joshua J. Berger 82 155 57 46 9 384
B. Ardouin 84 178 33 70 13 328
L. A. Barriocanal 233 54 86 98 10 382
C. C. Donner 213 179 92 44 9 389
Henrique Gottardello Zecchin 83 176 46 41 7 369
Adriana Marton 113 120 67 93 11 401
J. P. Randin 118 145 29 61 7 318

All Works

Loading papers...

Rankless by CCL
2026